Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1

Clinical Function Assignment of NAT2 Alleles by the Clinical Pharmacogenetics Implementation Consortium Pharmacogene Curation Expert Panel.

Clinical pharmacology and therapeutics·2026

Impact of N-Acetylation on DNA Damage and Oxidative Stress Responses in Mammalian Cells and Human Hepatocytes Treated with Hydralazine.

Biomolecules·2026

Impact of the University of Louisville Cancer Education Program.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026

PharmVar GeneFocus: NAT2-Genetic Variation and Updated Nomenclature.

Clinical pharmacology and therapeutics·2025

Arylamine N-Acetyltransferase 1 Knockout in Immortalized Human Bronchial Cells Results in a Reduction of Cellular Growth.

Gene reports·2025

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.

Clinical pharmacology and therapeutics·2025

Development and Validation of a Mechanism-Based Ba/F3-hGHR Bioassay for the Potency Assessment of Recombinant Human Growth Hormone.

Analytical biochemistry·2026

Camel Milk-Derived Extracellular Vesicles Using a Two-Step PEG Precipitation Strategy.

Analytical biochemistry·2026

Evaluation of a competitive immunochromatographic strip based on B. neotomae LPS for detecting antibodies against B. melitensis and B. abortus in cattle and goats.

Analytical biochemistry·2026

Development of immunoassay methods for ricin and application in the OPCW international proficiency test.

Analytical biochemistry·2026

A mechanistic classification framework for RT-qPCR inhibitors in wastewater-based epidemiology.

Analytical biochemistry·2026

Analytical performance comparison of Siemens Atellica CI1900 and Roche Cobas Pure integrated analyzers across spectrophotometric, ion-selective electrode and immunoassay parameters.

Analytical biochemistry·2026

Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives.

Pharmacology & therapeutics·2026

[Autism - Phenotypic variability].

Medicina·2026

Significant differences in phenotype and age of onset in an SPG4 family caused by whole SPAST deletion combined with a hemizygous S44L modifier.

Neurogenetics·2026

A Novel Mutation in ACTG1 as the Probable Cause of Nonsyndromic Hearing Loss in Chinese Han Population.

Neural plasticity·2026

Rare missense variants in NECTIN1 alter local protein structure and may contribute to non-syndromic cleft lip with or without palate.

Frontiers in genetics·2026

Two Novel Compound Heterozygous CDH23 Mutations Underlying Non-Syndromic Hearing Loss.

International journal of general medicine·2026

Related Experiment Videos

Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1

Related Concept Videos

Clinical Function Assignment of NAT2 Alleles by the Clinical Pharmacogenetics Implementation Consortium Pharmacogene Curation Expert Panel.

Impact of N-Acetylation on DNA Damage and Oxidative Stress Responses in Mammalian Cells and Human Hepatocytes Treated with Hydralazine.

Impact of the University of Louisville Cancer Education Program.

PharmVar GeneFocus: NAT2-Genetic Variation and Updated Nomenclature.

Arylamine N-Acetyltransferase 1 Knockout in Immortalized Human Bronchial Cells Results in a Reduction of Cellular Growth.

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.

Development and Validation of a Mechanism-Based Ba/F3-hGHR Bioassay for the Potency Assessment of Recombinant Human Growth Hormone.

Camel Milk-Derived Extracellular Vesicles Using a Two-Step PEG Precipitation Strategy.

Evaluation of a competitive immunochromatographic strip based on B. neotomae LPS for detecting antibodies against B. melitensis and B. abortus in cattle and goats.

Development of immunoassay methods for ricin and application in the OPCW international proficiency test.

A mechanistic classification framework for RT-qPCR inhibitors in wastewater-based epidemiology.

Analytical performance comparison of Siemens Atellica CI1900 and Roche Cobas Pure integrated analyzers across spectrophotometric, ion-selective electrode and immunoassay parameters.

Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives.

[Autism - Phenotypic variability].

Significant differences in phenotype and age of onset in an SPG4 family caused by whole SPAST deletion combined with a hemizygous S44L modifier.

A Novel Mutation in ACTG1 as the Probable Cause of Nonsyndromic Hearing Loss in Chinese Han Population.

Rare missense variants in NECTIN1 alter local protein structure and may contribute to non-syndromic cleft lip with or without palate.

Two Novel Compound Heterozygous CDH23 Mutations Underlying Non-Syndromic Hearing Loss.

Related Experiment Videos

Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1

Related Concept Videos

Related Articles